BillTracker

Concerning opioid use disorder treatment, prevention, and related services (Cody, Rodne, Harris)

AN ACT Relating to opioid use disorder treatment, prevention, and related services; amending RCW 71.24.585, 71.24.595, 71.24.560, 71.24.011, 69.41.095, 70.225.010, 70.225.040, and 70.168.090; amending 2005 c 70 s 1 (uncodified); adding new sections to chapter 71.24 RCW; adding a new section to chapter 70.225 RCW; adding a new section to chapter 74.09 RCW; and creating a new section.

SUMMARY OF 1ST SUBSTITUTE BILL COMPARED TO ORIGINAL BILL
The substitute bill: (1) requires the Department of Social and Health Services (DSHS) and the Health Care Authority (HCA) to create a program to connect certified peer counselors with individuals who have had a nonfatal overdose within the past 48 hours; (2) requires dispensers to submit information about controlled substances prescriptions to the prescription monitoring program (PMP) within one business day of dispensing, codifying what is required in rule; (3) authorizes pharmacists to partially fill prescriptions at the request of the patient or prescriber, so long as the total amount dispensed does not exceed the amount prescribed; (4) requires health care practitioners prescribing an opioid for the first time for outpatient use to discuss with the patient the risks of opioids and pain management alternatives; (5) requires the Department of Health to create a warning statement of the risks of opioids and information about the safe disposal of opioids; (6) requires seven types of health care practitioners licensed to prescribe controlled substances to complete one hour of Continuing Education on best practices for opioid prescribing, to register for the PMP following licensure or renewal or provide proof of registration, and sign an attestation that the provider has reviewed the prescribing rules, in order to prescribe opioids; (7) states that the Secretary of Health shall be responsible for coordinating the statewide response to the opioid epidemic; (8) allows emergency departments to directly distribute opioid overdose reversal medication to a patient at risk of opioid overdose; and (9) retains all sections of the underlying bill, but makes several changes including: removing access to the PMP for commercial health carriers; expanding the scope of the nonpharmacologic treatment recommendations for chronic pain to also include acute and sub-acute pain; and adding contingency sections for sections 2 through 5, in the event that House Bill 1388 or Senate Bill 5259 is enacted and changes the authority of behavioral health from the DSHS to the HCA.

HOUSE FLOOR AMENDMENTS
Exempts veterinarians from requirements to have in-person discussions with patients regarding the risks of opioids and pain management alternatives.

SENATE COMMITTEE (Health & Long Term Care) STRIKER AMENDMENT:
(1) Includes a requirement for the Department of Health (DOH) to establish a data collection plan for determining the number of opioid-related overdoses occurring in non-English speakers; (2) removes approval and verification requirements for electronic prescription systems; (3) clarifies the requirements for prescriber discussions with the patient for first-time opioid prescriptions to allow for telemedicine; (4) exempts prescribers who attest to completing opioid continuing medical education or prescribers who are permitted and providing medication-assisted treatment from having to take the onetime one hour training; adds language that the electronic health record's (EHR's) pricing must be in alignment with current industry pricing for prescription monitoring program (PMP) integration; (5) limits PMP integration requirements to top 3 EHR's with the largest market share in the state, and extends the due date to July 1, 2019; (6) requires DOH to convene a stakeholder work group to study best practices regarding data sharing, and the challenges associated with PMP integration; (7) requires DOH to submit a report to the legislature with the work group's findings by November 15, 2018. (8) Specifies that providers must inform patients of all evidence-based treatment options including controlled and non-controlled medications.

SENATE COMMITTEE (Ways & Means) STRIKER AMENDMENT
(1) Adds substance use disorder treatment facilities to the list of allied opioid use disorder community partners. (2) Clarifies that treatment options available include both controlled and noncontrolled medications. (3) Requires DOH to develop a data collection plan for determining the number of opioid-related overdoses for non-English speakers. (4) Removes approval and verification requirements for electronic prescription systems. (5) Clarifies the requirements for prescriber discussions with the patient for first-time opioid prescriptions. (6) Exempts prescribers who attest to completing opioid continuing medical education or prescribers who are permitted and providing medication-assisted treatment from having to take the onetime one hour training. (7) Clarifies that the board/commission may adopt additional continuing education requirements related to prescribing opioids, if necessary. (8) Clarifies that prescribers must complete the required onetime best practices in opioid prescribing continuing education class during the first reporting period after January 1, 2019, or during one's initial reporting period upon initial licensure. (9) Adds language that the EHR's pricing must be in alignment with current industry pricing for PMP integration. (10) Limits PMP integration requirements to the top three EHRs with the largest market share in the state, and extends the due date to July 1, 2019. (11) Requires DOH and HCA to convene a stakeholder work group to study best practices regarding data sharing, and the challenges associated with PMP integration. (12) Requires DOH to submit a report to the Legislature with the work group's findings by November 15, 2018.

Hearing Date: Thursday, February 15, 2018 -- 10:00 am

WA State Legislature Link:
http://app.leg.wa.gov/billsummary?BillNumber=2489&Year=2018    (opens a new browser tab)